Guido Giordano

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 12

Top Topics

Radical Prostatectomy

Small Cell Lung Cancer

Top Venues

Gastroenterology research and practice

Cancer medicine

Therapeutic advances in medical oncology

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Guido Giordano, Michele Milella, Matteo Landriscina, Francesca Bergamo, Giuseppe Tirino, Antonio Santaniello, Alberto Zaniboni, Enrico Vasile, Ferdinando De Vita, Giovanni Lo Re, Vanja Vaccaro, Elisa Giommoni, Donato Natale, Raffaele Conca, Daniele Santini, Luigi Maiorino, Gianni Sanna, Vincenzo Ricci, Aldo Iop, Vincenzo Montesarchio, Letizia Procaccio, Silvia Noventa, Roberto Bianco, Antonio Febbraro, Sara Lonardi, Giampaolo Tortora, Isabella Sperduti, Davide Melisi
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment. Cancer medicine 13 (12) (2024)
Guido Giordano, Michele Milella, Matteo Landriscina, Francesca Bergamo, Giuseppe Tirino, Antonio Santaniello, Alberto Zaniboni, Enrico Vasile, Ferdinando De Vita, Giovanni Lo Re, Vanja Vaccaro, Elisa Giommoni, Donato Natale, Raffaele Conca, Daniele Santini, Luigi Maiorino, Gianni Sanna, Vincenzo Ricci, Aldo Iop, Vincenzo Montesarchio, Letizia Procaccio, Silvia Noventa, Roberto Bianco, Antonio Febbraro, Sara Lonardi, Giampaolo Tortora, Isabella Sperduti, Davide Melisi
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment. Cancer medicine 13 (12) (2024)
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, Guido Giordano, Piergiorgio Di Tullio, Felicia Maria Maselli, Matteo Landriscina, Vincenza Conteduca
Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer? Therapeutic advances in medical oncology 16 (2024)
Guido Giordano, Michele Milella, Matteo Landriscina, Francesca Bergamo, Giuseppe Tirino, Antonio Santaniello, Alberto Zaniboni, Enrico Vasile, Ferdinando De Vita, Giovanni Lo Re, Vanja Vaccaro, Elisa Giommoni, Donato Natale, Raffaele Conca, Daniele Santini, Luigi Maiorino, Gianni Sanna, Vincenzo Ricci, Aldo Iop, Vincenzo Montesarchio, Letizia Procaccio, Silvia Noventa, Roberto Bianco, Antonio Febbraro, Sara Lonardi, Giampaolo Tortora, Isabella Sperduti, Davide Melisi
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment. Cancer medicine 13 (12) (2024)
Marianna Garofoli, Brigida Anna Maiorano, Giuseppina Bruno, Guido Giordano, Piergiorgio Di Tullio, Felicia Maria Maselli, Matteo Landriscina, Vincenza Conteduca
Androgen receptor, PARP signaling, and tumor microenvironment: the 'perfect triad' in prostate cancer? Therapeutic advances in medical oncology 16 (2024)
Guido Giordano, Raffaele Ivan Cincione, Francesca Losavio, Tiziano Senia, Arianna Aquilini Mummolo, Mario Pacilli, Vincenzo Lizzi, Giuseppina Bruno, Annamaria Piscazzi, Vincenza Conteduca, Matteo Landriscina
Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer. The oncologist (2023)
Andrea Remo, Federica Grillo, Luca Mastracci, Michele Simbolo, Matteo Fassan, Maria Paola Cecchini, Giuseppe Miscio, Antonio Sassano, Paola Parente, Alessandro Vanoli, Giovanna Sabella, Guido Giordano, Emanuele Damiano Luca Urso, Luigi Cerulo, Aldo Scarpa, Francesco Fiorica, Massimo Pancione
Loss of Primary Cilia Potentiates BRAF/MAPK Pathway Activation in Rhabdoid Colorectal Carcinoma: A Series of 21 Cases Showing Ciliary Rootlet CoiledCoil ( CROCC ) Alterations. Genes 14 (5) (2023)
Elisa Giommoni, Evaristo Maiello, Vanja Vaccaro, Ermanno Rondini, Caterina Vivaldi, Giampaolo Tortora, Laura Toppo, Guido Giordano, Tiziana Pia Latiano, Cinzia Lamperini, Serena Pillozzi, Luca Boni, Lorenzo Antonuzzo, Francesco Di Costanzo
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study). Current oncology (Toronto, Ont.) 28 (3) (2021)
Donato Lacedonia, Matteo Landriscina, Giulia Scioscia, Pasquale Tondo, Incoronata Caccavo, Giuseppina Bruno, Guido Giordano, Annamaria Piscazzi, Maria Pia Foschino Barbaro
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma. Journal of oncology 2021 (2021)
Massimo Pancione, Luigi Cerulo, Andrea Remo, Guido Giordano, Álvaro Gutierrez-Uzquiza, Paloma Bragado, Almudena Porras
Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process. Biomolecules 11 (5) (2021)
Paola Parente, Pietro Parcesepe, Claudia Covelli, Nunzio Olivieri, Andrea Remo, Massimo Pancione, Tiziana Pia Latiano, Paolo Graziano, Evaristo Maiello, Guido Giordano
Crosstalk between the Tumor Microenvironment and Immune System in Pancreatic Ductal Adenocarcinoma: Potential Targets for New Therapeutic Approaches. Gastroenterology research and practice 2018 (2018)
Pietro Parcesepe, Guido Giordano, Carmelo Laudanna, Antonio Febbraro, Massimo Pancione
Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer. Gastroenterology research and practice 2016 (2016)
Guido Giordano, Antonio Febbraro, Michele Venditti, Serena Campidoglio, Nunzio Olivieri, Katia Raieta, Pietro Parcesepe, Giusy Carmen Imbriani, Andrea Remo, Massimo Pancione
Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept. Gastroenterology research and practice 2014 (2014)
Massimo Pancione, Guido Giordano, Andrea Remo, Antonio Febbraro, Lina Sabatino, Erminia Manfrin, Michele Ceccarelli, Vittorio Colantuoni
Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis. Journal of immunology research 2014 (2014)